Unfamiliar Case When Covering for Another Physician Makes Oncology Physicians Experience Increased Effort

Researchers have found that the perception of increased levels of workload is high among radiation oncology physicians who come across unfamiliar cases when covering for another physician.

Researchers at University of North Carolina have found that the perception of increased levels of workload is high among radiation oncology physicians who come across unfamiliar cases when covering for another physician and this perception may also affect their performance.

In a paper presented at the 2013 American Society for Radiation Oncology conference, study authors Prithima Mosaly, PhD, and Lukasz Mazur, PhD, assistant professors in the UNC Department of Radiation Oncology; Bhishamjit Chera, MD, assistant professor of radiation oncology and Lawrence Marks, MD, Sidney K. Simon Distinguished Professor of Oncology Research and Chair, found a significant decrease in performance and confidence when physicians were asked to plan the treatment of an unfamiliar patient.

Pheochromocytoma | Adrenal Gland Tumor: Causes, Symptoms, Diagnosis, Treatment, Prevention
Pheochromocytoma is a rare tumor of the adrenal glands that secretes the catecholamines, adrenaline and noradrenaline. Symptoms, diagnosis, treatment of adrenal gland tumor are explained in detail.

Eight radiation oncologists participating in the study, three experienced physicians and five resident physicians, attended two sessions where they were tasked with planning the procedure of a patient based on information from an electronic medical record. Researchers measured the subjective and quantitative experiences of the participating physicians during each session.

During the first session, designed to simulate a "cross-coverage" scenario, radiation oncology physicians were presented with the records of an unfamiliar patient undergoing a routine radiological procedure - palliative 2-field opposed lateral brain fields. The second session represented a "regular-coverage" scenario where the radiation oncology physicians were presented with the same case after 48 hours.

After each session, the physicians evaluated their experience using the National Aeronautics and Space Administration-Task Load Index (NASA-TLX). Performance was measured using completion time and willingness to approve the generated plan. Overall, the results during cross-coverage revealed a significant increase in perceived workload as quantified by NASA-TLX score and decrease in performance as quantified by longer completion time and reduced approval rate.

Carcinoid Tumors - Carcinoid Syndrome - Symptoms, Signs, Diagnosis & Treatment
Carcinoid tumors is a benign tumor that results in carcinoid syndrome. Only 8 to 10% of all carcinoid tumors are associated with the carcinoid syndrome.

The radiation oncology physicians presented with unfamiliar cases in the first session experienced a relatively-high perceived workload and a reduced level of performance. They took more time to complete the tasks and were more reluctant to approve a treatment plan, when compared to the second session where they were more familiar with the case. The level of professional experience of the radiation oncology physicians did not influence the results.

"We had people not willing to approve treatment when in a cross-coverage scenario, but we had 100 percent treatment approval when they were under regular coverage scenario," said Mosaly.

About Brain Tumor
Brain tumors are the abnormal growth of brain cells that may be benign or metastatic. Brain tumors account for about 2.4% of all the tumor diagnosesandare most challenging due to their critically delicate location.

The team's research builds on insights from industries such as aviation, nuclear power plants and transportation that have relied on similar variety of workload assessments to develop safety standards for decades. With the growing use of information technology systems, Mazur said that it is important to develop workload limits for human-computer interaction in order to optimize patient safety.

"It is important for us to look for these boundaries, so that when we have a system it actually builds on human strengths and understands the limitations," said Mazur.

Tumor Markers - For Cancer Diagnosis and Prognosis
An ideal tumor marker for a cancer should be specific to that cancer and not generate false positive results.

Source-Eurekalert